Drug Pricing

By Jordan Paradise
In Conflicts of Interest
Dec 11th, 2014
0 Comments
By Jordan Paradise This week, the New York Times reported that ophthalmologists who were paid to promote Genentech’s drug Lucentis (ranibizumab) were among the top billers of the drug to federal programs, exceeding the prescribing amounts of more than 75% of their peers.  Lucentis, approved in 2006 by the Food and Drug Administration (FDA), is indicated […]...
By Kate Greenwood
In Drug Pricing
Aug 27th, 2013
1 Comment
Here at Seton Hall Law, the halls are filled with the sounds of students again, which means our summer-long blog hiatus has come to an end.  We’re excited to get back to blogging at Health Reform Watch! As always, the blog will feature analysis and commentary from Seton Hall’s health law faculty and Recommended Reading […]...
By Frank Pasquale
In Drug Pricing
Apr 21st, 2011
3 Comments
One rare point of elite consensus is that the US needs to reduce health care costs. Frightening graphs expose America as a spendthrift outlier. Before he decamped to Citigroup, the President’s OMB director warned about how important it was to “bend the cost curve.” The President’s opponents are even more passionate about austerity. Journalists a...
By Jennifer Jascoll
In Drug Pricing
Apr 20th, 2011
0 Comments
Listen up, Hoboken, Newark, and Orange residents.  There’s a new prescription discount program in town: Coast2Coast Rx Card.  Well, the program isn’t all that new to the area: Newark launched it last year and Hoboken launched it in January.  However, I didn’t learn about Coast2Coast Rx Card until I filled a prescription at my local […]...
By Frank Pasquale
In Bioethics
Apr 7th, 2011
0 Comments
As Kevin Outterson & Aaron Kesselheim have been arguing for years, antibiotic resistance is a huge and growing problem. The Guardian’s Frank Swain offers an international perspective: An unusually hardy strain of Klebsiella pneumoniae was isolated from a 59-year-old Swedish patient who had been treated in a New Delhi hospital. The bacterium was found to be in...